Atlas Trials

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.

Clinical trial NCT00087594 · COMPLETED

Trial details

NCT number
NCT00087594
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2003-11-01
Primary completion
2006-10-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.